Pulmonx's Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform are designed to assess and treat patients. In Q2 2025, the company achieved total revenue of $23.9 million, representing a 15% year-over-year increase, driven by strong international growth of 32% ($9.1 million), while U.S. revenue grew 6% ($14.7 million).
Cyborg Score Rationale
Pulmonx stock trades at $3.77 per share with a market capitalization of $150.03M, representing a -90.41% return since its October 2020 IPO listing at $39.31. The company maintains a strong gross margin of 72% but reported a net loss of $15.2 million in Q2 2025. While revenue growth is solid with 15% YoY increase, the company faces significant profitability challenges.
Top Insights
Q2 2025 revenue of $23.9M showed 15% YoY growth with international markets expanding faster (32%) than domestic U.S. market (6%)
Company maintains healthy 72% gross margin despite significant net losses, indicating product economics are sound but scale is insufficient
Strong cash position of $101.74M can cover annual cash burn of $32.98M for over three years, providing runway for growth initiatives
Recent executive hires including new CFO in Q4 2025 suggest potential strategic pivots or operational restructuring to address profitability
Named Competitors
Endobronchial Valve Systems — Alternative minimally invasive approaches to severe emphysema treatment
Lung Volume Reduction Surgery — Invasive alternative to Zephyr Valve therapy for emphysema management
Pulmonary Rehabilitation Programs — Conservative management approach for COPD/emphysema patients
Recent Developments
(December 2025) New CFO Derrick Sung and other executives granted significant equity awards (1,625,000 shares total) under 2025 Inducement Plan
(September 2025) Management participation in Wells Fargo Healthcare Conference and Lake Street Best Ideas Growth Conference
(Q2 2025) Total revenue of $23.9M with 15% YoY growth; international revenue grew 32% to $9.1M
Open the full interactive Pulmonx Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.